Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Investing.com Gold reports: Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says. Full body text was unavailable at ingest time, so this brief is based on headline context.